SEC Form D private-offering filing

Ceretype Neuromedicine, Inc.

Name: Ceretype Neuromedicine, Inc. - new SEC Form D private-offering filing, Cambridge, MA
Published: 2025-12-18

A new SEC Form D private-offering notice from Cambridge, MA, a $400,000 filer-stated offering target in Biotech. The source filing is one click away.

Ceretype Neuromedicine, Inc. site↗ Verified via SEC Form D

Biotechnology company using functional MRI based brain activity biomarkers to support neuropsychiatric drug development; a spinout of Harvard Medical School and Brigham and Women's Hospital research.

Filed 2025-12-18Filed to raise $400,000First money in 2024-08-06Raised so far $400,000HQ (as filed) Cambridge, MASector Biotech ✓Stage (inferred) Pre-seedCall status Late filing

Source linked the Form D on EDGAR↗Website verified ceretype.com↗Named in the filing 3 executives & directors

Open this row on the live feed →More new filings in Massachusetts →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.